United States · Bill · S
S. 4191 (116th)
United States Pharmaceutical Supply Chain Review Act
Introduced
2 July 2020
Last action
—
Status
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Sponsors
—
Subjects
Discovery layer
Source updated
14 January 2025
Summary
United States Pharmaceutical Supply Chain Review Act This bill requires the Federal Trade Commission to submit annually to Congress a report on foreign investment in the U.S. pharmaceutical industry. The report shall address, among other topics, the effect of the industry's reliance on foreign manufacturing.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate · EN · 2 July 2020
Introduced in Senate (PDF)
Introduced in Senate · EN · 2 July 2020
Introduced in Senate
summary · EN · 2 July 2020
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/senate-bill/4191
- Open data entity: https://api.congress.gov/v3/bill/116/s/4191